Beacon Pointe Advisors LLC Lowers Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Beacon Pointe Advisors LLC lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 57.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,686 shares of the pharmacy operator’s stock after selling 48,298 shares during the period. Beacon Pointe Advisors LLC’s holdings in Walgreens Boots Alliance were worth $1,357,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also made changes to their positions in the company. GoalVest Advisory LLC increased its position in shares of Walgreens Boots Alliance by 10,828.6% in the 2nd quarter. GoalVest Advisory LLC now owns 765 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 758 shares during the period. WFA of San Diego LLC purchased a new position in Walgreens Boots Alliance in the 2nd quarter valued at about $32,000. Tompkins Financial Corp lifted its stake in Walgreens Boots Alliance by 215.7% in the 1st quarter. Tompkins Financial Corp now owns 947 shares of the pharmacy operator’s stock valued at $42,000 after buying an additional 647 shares in the last quarter. Baystate Wealth Management LLC lifted its stake in Walgreens Boots Alliance by 209.4% in the 2nd quarter. Baystate Wealth Management LLC now owns 1,216 shares of the pharmacy operator’s stock valued at $46,000 after buying an additional 823 shares in the last quarter. Finally, CX Institutional purchased a new position in Walgreens Boots Alliance in the 2nd quarter valued at about $47,000. 57.33% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 16,570 shares of the firm’s stock in a transaction that occurred on Thursday, November 17th. The shares were sold at an average price of $39.89, for a total value of $660,977.30. Following the completion of the transaction, the director now owns 5,515 shares of the company’s stock, valued at approximately $219,993.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Nancy M. Schlichting sold 16,570 shares of Walgreens Boots Alliance stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $39.89, for a total transaction of $660,977.30. Following the completion of the sale, the director now directly owns 5,515 shares of the company’s stock, valued at approximately $219,993.35. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Kevin M. Ban sold 10,303 shares of Walgreens Boots Alliance stock in a transaction on Friday, November 18th. The stock was sold at an average price of $40.19, for a total transaction of $414,077.57. Following the sale, the executive vice president now directly owns 27,916 shares of the company’s stock, valued at $1,121,944.04. The disclosure for this sale can be found here. 17.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

WBA has been the topic of a number of research reports. Cowen raised shares of Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and raised their price target for the company from $43.00 to $54.00 in a research note on Tuesday. Mizuho decreased their price target on shares of Walgreens Boots Alliance to $36.00 in a research note on Thursday, October 13th. Cowen raised shares of Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and raised their price target for the company from $43.00 to $54.00 in a research note on Tuesday. StockNews.com lowered shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Wednesday, October 5th. Finally, JPMorgan Chase & Co. upgraded shares of Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and set a $42.00 price objective for the company in a report on Friday, November 18th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $43.23.

Walgreens Boots Alliance Stock Down 0.1 %

Walgreens Boots Alliance stock opened at $41.76 on Thursday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $30.39 and a fifty-two week high of $55.00. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.38 and a current ratio of 0.75. The firm has a 50 day moving average price of $35.22 and a 200 day moving average price of $38.10. The company has a market capitalization of $36.11 billion, a PE ratio of 8.35, a price-to-earnings-growth ratio of 1.86 and a beta of 0.71.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last posted its earnings results on Thursday, October 13th. The pharmacy operator reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.03. Walgreens Boots Alliance had a net margin of 3.27% and a return on equity of 14.39%. The firm had revenue of $32.45 billion during the quarter, compared to the consensus estimate of $32.17 billion. During the same quarter last year, the firm earned $1.17 EPS. The firm’s revenue for the quarter was down 5.3% on a year-over-year basis. Research analysts expect that Walgreens Boots Alliance, Inc. will post 4.5 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 12th. Shareholders of record on Tuesday, November 15th will be given a $0.48 dividend. The ex-dividend date is Monday, November 14th. This represents a $1.92 annualized dividend and a yield of 4.60%. Walgreens Boots Alliance’s dividend payout ratio is presently 38.40%.

Walgreens Boots Alliance Company Profile

(Get Rating)

Walgreens Boots Alliance, Inc operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Recommended Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.